Evaluation of a Decision Support Tool
- Conditions
- Decision Making, SharedHypertensionMedication AdherencePatient-Centered Outcomes Research
- Interventions
- Behavioral: Interview OnlyBehavioral: ControlBehavioral: Interview plus decision support tool
- Registration Number
- NCT02060981
- Lead Sponsor
- Brigham and Women's Hospital
- Brief Summary
Investigators will conduct a randomized trial with patients, through one-on-one interviews, to evaluate their understanding of and willingness to use a decision support tool and to determine if receiving and discussing the decision support tool improves the likelihood that a patient is adherent to a new antihypertensive medication.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 140
- does not pick up a prescription for a new antihypertensive medication within 14 days as identified by CVS pharmacy, their retail pharmacy provider.
- High blood pressure diagnosis
- under age 25.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Interview only Interview Only Patients will be asked to participate in an interview regarding their views on hypertension and taking medications to treat hypertension. Control Control Control group patients will then be mailed an American Heart Association brochure regarding hypertension and a brief, 5-question, paper-based survey. These patients will be asked to review the brochure, complete the survey, and mail it back to the research team using a self-addressed stamped envelope. Interview plus decision support tool Interview plus decision support tool Patients will be asked to participate in an interview regarding their views on hypertension and taking medications to treat hypertension, and to provide feedback regarding a new tool for helping patients learn more about their medications. Interview plus patients' index date for follow-up is the date of the scheduled interview.
- Primary Outcome Measures
Name Time Method Cumulative incidence of antihypertensive medication fills 6 months The proportion of patients in each group who picked up a prescription for an antihypertensive medication in any class during the follow-up period. Investigators will calculate cumulative incidences among all patients, whether or not they successfully completed the interview or returned the paper-based survey (Intention to Treat) and among only those patients who did complete the interview or returned the paper-based survey (As Treated).
- Secondary Outcome Measures
Name Time Method Patient Interviews 5 months One-on-one structured interviews will ask about participants' preferences, attitudes and beliefs regarding primary adherence and/or use of a decision support tool.
Trial Locations
- Locations (1)
Brigham and Women's Hospital
🇺🇸Boston, Massachusetts, United States